The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial
EuroIntervention 2016;12:1239-1245 published online ahead of print November 2015. DOI: 10.4244/EIJY15M11_07
Pascal Vranckx1, MD, PhD; Marco Valgimigli2, MD, PhD; Stephan Windecker3, MD; Philippe Gabriel Steg4,5, MD; Christian Hamm6, MD, PhD; Peter Jüni7, MD; Hector M. Garcia-Garcia2,8, MD, PhD; Gerrit Anne van Es8, PhD; Patrick W. Serruys5*, MD, PhD;
1. Hartcentrum Hasselt, Hasselt, Belgium; 2. Erasmus MC, Rotterdam, The Netherlands; 3. Bern University Hospital, Bern, Switzerland; 4. Université Paris Diderot-Sorbonne Paris Cité, DHU-FIRE, AH-HP and INSERM U-1148, Paris, France; 5. Imperial College Lon
Aims: The GLOBAL LEADERS trial is a superiority study in patients undergoing percutaneous coronary intervention, with a uniform use of Biolimus A9-eluting stents (BES) and bivalirudin. GL